Literature DB >> 25796433

Genomics in the land of regulatory science.

Weida Tong1, Stephen Ostroff2, Burton Blais3, Primal Silva3, Martine Dubuc3, Marion Healy4, William Slikker5.   

Abstract

Genomics science has played a major role in the generation of new knowledge in the basic research arena, and currently question arises as to its potential to support regulatory processes. However, the integration of genomics in the regulatory decision-making process requires rigorous assessment and would benefit from consensus amongst international partners and research communities. To that end, the Global Coalition for Regulatory Science Research (GCRSR) hosted the fourth Global Summit on Regulatory Science (GSRS2014) to discuss the role of genomics in regulatory decision making, with a specific emphasis on applications in food safety and medical product development. Challenges and issues were discussed in the context of developing an international consensus for objective criteria in the analysis, interpretation and reporting of genomics data with an emphasis on transparency, traceability and "fitness for purpose" for the intended application. It was recognized that there is a need for a global path in the establishment of a regulatory bioinformatics framework for the development of transparent, reliable, reproducible and auditable processes in the management of food and medical product safety risks. It was also recognized that training is an important mechanism in achieving internationally consistent outcomes. GSRS2014 provided an effective venue for regulators andresearchers to meet, discuss common issues, and develop collaborations to address the challenges posed by the application of genomics to regulatory science, with the ultimate goal of wisely integrating novel technical innovations into regulatory decision-making. Published by Elsevier Inc.

Keywords:  Genomics; Next generation sequencing; Regulatory science

Mesh:

Year:  2015        PMID: 25796433     DOI: 10.1016/j.yrtph.2015.03.008

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  3 in total

Review 1.  A Primer on Infectious Disease Bacterial Genomics.

Authors:  Tarah Lynch; Aaron Petkau; Natalie Knox; Morag Graham; Gary Van Domselaar
Journal:  Clin Microbiol Rev       Date:  2016-09-07       Impact factor: 26.132

Review 2.  The FDA's Experience with Emerging Genomics Technologies-Past, Present, and Future.

Authors:  Joshua Xu; Shraddha Thakkar; Binsheng Gong; Weida Tong
Journal:  AAPS J       Date:  2016-04-26       Impact factor: 4.009

3.  Regulatory landscape of nanotechnology and nanoplastics from a global perspective.

Authors:  Jacqueline Allan; Susanne Belz; Arnd Hoeveler; Marta Hugas; Haruhiro Okuda; Anil Patri; Hubert Rauscher; Primal Silva; William Slikker; Birgit Sokull-Kluettgen; Weida Tong; Elke Anklam
Journal:  Regul Toxicol Pharmacol       Date:  2021-02-19       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.